J Korean Acad Periodontol.  2008 Mar;38(1):41-50. 10.5051/jkape.2008.38.1.41.

Purification and biological activity of recombinant human bone morphogenetic protein-2 produced by E. coli expression system

Affiliations
  • 1Research Development Institute, Cowellmedi Co. LTD., Korea.
  • 2Department of Dentistry, College of Medicine, Kwandong University, Myongji Hospital, Korea.
  • 3Depatment of Biological Science, College of Natural science, Pusan National University, Korea.
  • 4Department of Periodontology, Research Institute for Periodontal Regeneration, College of Dentistry, Yonsei University, Korea. kscho@yuhs.ac

Abstract

PURPOSE
Bone morphogenetic protein-2(BMP-2) has been shown to possess significant osteoinducitve potential. There have been attempts to overcome a limitation of mass production, and economical efficiency of BMP. The aim of this study was to produce recombinant human BMP-2(rhBMP-2) from E. coli in a large scale and evaluate its biological activity.
MATERIALS AND METHODS
The E.coli strain BL21(DE3) was used as a host for rhBMP-2 production. Dimerized rhBMP-2 was purified by affinity chromatography using Heparin column. To determine the physicochemical properties of the rhBMP-2 expressed in E. coli, we examined the HPLC profile and performed Western blot analysis. The effect of the purified rhBMP-2 dimer on osteoblast differentiation was examined by alkaline phosphatase (ALP) activity and representing morphological change using C2C12 cell.
RESULTS
E. coli was genetically engineered to produce rhBMP-2 in a non-active aggregated form. We have established a method which involves refolding and purifying a folded rhBMP-2 dimer from non-active aggregates. The purified rhBMP-2 homodimer was characterized by SDS-PAGE as molecular weight of about 28kDa and eluted at 34% acetonitrile, 13.27 min(retention time) in the HPLC profile and detected at Western blot. The purified rhBMP-2 dimer stimulated ALP activity and induced the transformation from myogenic differentiation to osteogenic differentiation.
CONCLUSION
rhBMP-2 was produced in E. coli using genetic engineering. The purified rhBMP-2 dimer stimulated ALP activity and induced the osteogenic differentiation of C2C12 cells.

Keyword

E.coli; rhBMP-2; purification; alkaline phosphatase

MeSH Terms

Acetonitriles
Alkaline Phosphatase
Blotting, Western
Bone Morphogenetic Protein 2
Chromatography, Affinity
Chromatography, High Pressure Liquid
Durapatite
Electrophoresis, Polyacrylamide Gel
Genetic Engineering
Heparin
Humans
Molecular Weight
Osteoblasts
Recombinant Proteins
Sprains and Strains
Transforming Growth Factor beta
Acetonitriles
Alkaline Phosphatase
Bone Morphogenetic Protein 2
Durapatite
Heparin
Recombinant Proteins
Transforming Growth Factor beta

Cited by  4 articles

Analysis of attachment, proliferation and differentiation response of human mesenchymal stem cell to various implant surfaces coated with rhBMP-2
In-Ku Lee, In-Ho Han, Sun-Wook Hwang, Jae-Jun Ryu
J Korean Acad Prosthodont. 2012;50(1):44-52.    doi: 10.4047/jkap.2012.50.1.44.

Effect of rhBMP-2 produced by Escherichia coli expression system on bone formation in rat calvarial defects
Suk-Hoon Kwon, Hyun-Chang Lim, Kyung-Hee Choi, Min-Soo Kim, Ji-Hyun Lee, Ui-Won Jung, Jeong-Ho Yun, Chang-Sung Kim, Seong-Ho Choi, Kyoo-Sung Cho
J Korean Acad Periodontol. 2009;39(1):77-86.    doi: 10.5051/jkape.2009.39.1.77.

Improvement of osteogenic potential of biphasic calcium phosphate bone substitute coated with two concentrations of expressed recombinant human bone morphogenetic protein 2
Hyunmin Choi, No-Je Park, Otgonbold Jamiyandorj, Kyung-Hee Choi, Min-Ho Hong, Seunghan Oh, Young-Bum Park, Sungtae Kim
J Periodontal Implant Sci. 2012;42(4):119-126.    doi: 10.5051/jpis.2012.42.4.119.

Improvement of the osteogenic potential of ErhBMP-2-/EGCG-coated biphasic calcium phosphate bone substitute: in vitro and in vivo activity
Jae-ho Hwang, Seunghan Oh, Sungtae Kim
J Periodontal Implant Sci. 2019;49(2):114-126.    doi: 10.5051/jpis.2019.49.2.114.

Full Text Links
  • JKAPE
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr